1.Preliminary assessment of adverse side effects of some procedure of chemotherapy against malignancy of hemopoietic organs
Journal of Practical Medicine 2003;463(10):44-46
Most of chemical drafts that treatment malignant disease at blood- forming organs have side effects as: reduce aleukemia, glomerule, blood pigment, increase ure, creatinin or nauseate, voltmit, lose hair. However, rate and level are different in each of drafts. The other drafts, that made side effects are Doxorubicin + Ara.C (P3), MOPP (P2), CHOP (P1) and VAD (P4). Ara.C + Depersolon (P7), Hydrea + Ara.C (P6) drafts and especially is only use single Hydrea dafts that has little side-effect
Hematologic Neoplasms
;
drug therapy
;
Pharmaceutical Preparations
5.Colon Cancer in Behcet's Disease.
Ji Eun LEE ; Jang Won SOHN ; Kyu Hyung LEE ; Youn Sun PARK ; Kook Hyun KIM ; Jae Won CHOI ; Jong Ryul EUN ; Byung Ik JANG ; Tae Nyeun KIM
Yeungnam University Journal of Medicine 2006;23(1):124-130
Behcet's disease has rarely been reported in association with malignant diseases. In most cases the autoimmune nature of the disease itself or immunosuppressive drug use has been blamed for malignant transformation. Solid tumors in addition to lymphoid and hematological malignancies are also seen during the course of Behcet's disease. We present here a case of colon cancer in a 40-year-old man with Behcet's disease. A near total colectomy was performed and postoperative chemotherapy and radiotherapy was administered to treat visceral peritoneal invasion. Recurrent evidence was not found. We present the clinical details of this rare case of colon cancer with Behcet's disease.
Adult
;
Colectomy
;
Colon*
;
Colonic Neoplasms*
;
Drug Therapy
;
Hematologic Neoplasms
;
Humans
;
Radiotherapy
6.Exacerbation of Disseminated Superficial Actinic Porokeratosis in a Patient with Colon Cancer.
Kyung Min KIM ; Ji Hyun LEE ; Tae Yoon KIM
Korean Journal of Dermatology 2015;53(6):462-465
Disseminated superficial actinic porokeratosis, a variant of porokeratosis, is an uncommon, hereditary or acquired keratinization disorder. It is characterized histologically by cornoid lamella and clinically by central atrophy with elevated borders. Porokeratosis lesions may be triggered by UV light exposure, infection, hematopoietic malignancies, or immunosuppression, but are rarely reported associated with malignancies of visceral organs. We herein report an unusual case of a patient with colon cancer who noted sudden exacerbation of a previously unrecognized disseminated superficial actinic porokeratosis lesion after being treated with chemotherapy.
Atrophy
;
Colon*
;
Colonic Neoplasms*
;
Drug Therapy
;
Hematologic Neoplasms
;
Humans
;
Immunosuppression
;
Porokeratosis*
;
Ultraviolet Rays
7.The Effect of a Discharge Education Program for Readmitted Chemotherapy Patients on Compliance with Sick Role Behavior and Educational Satisfaction.
Su Ol KIM ; Mi Hee PARK ; So Myeong KIM
Asian Oncology Nursing 2015;15(3):156-162
PURPOSE: This study was designed to evaluate the effects of a discharge education program for hospitalized readmitted patients with chemotherapy-in terms of sick role behavior and educational satisfaction. METHODS: The data were collected with a nonequivalent control group non-synchronized design and were analyzed with a nonequivalent control group pre-posttest design. The subjects included 49 patients with cancer, 25 in the experimental group, and 24 in the control group. Data were analyzed with spss win 21, chi2-tests, paired t-tests, and independent t-tests. RESULTS: The experimental group was educated according to their needs at discharge, and they showed higher compliance with sick role behavior. CONCLUSION: To improve compliance with sick role behavior, readmitted hematologic neoplasms chemotherapy patients should receive discharge education according to their needs at the clinic by using an educational manual.
Compliance*
;
Drug Therapy*
;
Education*
;
Hematologic Neoplasms
;
Humans
;
Patient Satisfaction
;
Sick Role*
9.Methylation status of multidrug resistance (mdr1) gene and its correlation with expression of mdr1 gene in patients with hematologic malignancies.
Yan ZHU ; Shu-Lan WU ; Ding-Fang BU ; Yuan LI ; Qiang ZHU ; Xiang-Hong CAO
Journal of Experimental Hematology 2004;12(1):6-10
To investigate the correlation between methylation and expression of multidrug resistance (mdr1) gene, restriction endonuclease HpaII combined with competitive PCR technique was used to quantitatively detect the methylation status of two CCGG sites located at -110 and -50 bp (region I and II) up to the transcription start site in mdr1 promoter in 54 AL and 9 MM patients. Semi-quantitative RT-PCR was used to detect the expression level of mdr1 gene. The results showed that inverse correlation between methylation rate of either region or total methylation rate and expression of mdr1 gene was observed. The correlation in the region I (r = -0.64) was closer than that in the region II (r = -0.4). High expression rate of mdr1 ascended significantly in low methylation group (n = 36) (P < 0.001). In comparison with chemotherapy sensitive group (n = 8), the methylation rate in refractory AL patients (n = 16) was lower (P = 0.05) in the region I, P < 0.05 in the region II and total regions. Comparing with the untreated patients (n = 36), the methylation rate in the region I and total methylation rate were lower in the patients with chemotherapy (n = 14) (P < 0.05). The methylation rate in the region II was also decreased after chemotherapy, however, no statistical significance was shown (P > 0.05). Increased mdr1 expression level accompanying with decreased methylation rate after chemotherapy was found, although no significant difference was shown (P = 0.06). It is concluded that the expression level of mdr1 gene was associated with the methylation status of CCGG in -110 and -50 bp upstream to the transcription start site, especially the -110 site. In both the patients treated with chemotherapy and the refractory patients, the methylation level of mdr1 gene decreased relatively. The rising expression of mdr1 gene after chemotherapy was associated with the decrease of methylation level.
DNA Methylation
;
Genes, MDR
;
Hematologic Neoplasms
;
drug therapy
;
genetics
;
Humans
;
Reverse Transcriptase Polymerase Chain Reaction